Evidence map›Paper›PMID 34395970›Full record

ArticleACS omega2021

Physical and Biological Properties of 5-Fluorouracil Polymer-Coated Magnetite Nanographene Oxide as a New Thermosensitizer for Alternative Magnetic Hyperthermia and a Magnetic Resonance Imaging Contrast Agent: In Vitro and In Vivo Study.

Leila Kiamohammadi, Leili Asadi, Sakine Shirvalilou, Samideh Khoei, Sepideh Khoee, Maryam Soleymani, Soraya Emamgholizadeh Minaei

Abstract read
In one paragraph

Article in ACS omega, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. APTES-functionalized GdRSC advances · 2026
    Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Advances in Biologically Applicable Graphene-Based 2D Nanomaterials.International journal of molecular sciences · 2022
    Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Leila KiamohammadiDepartment of Medical Physics, School of Medicine, Iran University of Medical Sciences, Tehran 1449614535, Iran.
Leili AsadiDepartment of Medical Physics, School of Medicine, Iran University of Medical Sciences, Tehran 1449614535, Iran.
Sakine ShirvalilouFinetech in Medicine Research Centre, Iran University of Medical Sciences, Tehran 1449614535, Iran.ORCID https://orcid.org/0000-0003-3213-8824
Samideh KhoeiFinetech in Medicine Research Centre, Iran University of Medical Sciences, Tehran 1449614535, Iran.ORCID https://orcid.org/0000-0001-9357-0229
Sepideh KhoeeDepartment of Polymer Chemistry, School of Chemistry, College of Science, University of Tehran, Tehran 14155 6455, Iran.ORCID https://orcid.org/0000-0001-7297-8743
Maryam SoleymaniDepartment of Polymer Chemistry, School of Chemistry, College of Science, University of Tehran, Tehran 14155 6455, Iran.
Soraya Emamgholizadeh MinaeiDepartment of Medical Physics and Imaging, Urmia University of Medical Sciences, Urmia 571478334, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study reports a new procedure for utilizing 5-fluorouracil (5-Fu)-loaded polycaprolactone (PCL)/chitosan-covered magnetite nanographene oxide (5-Fu/SPION/NGO@PCL-LMWC) as a platform for synergistic thermo-chemotherapy. In fact, superparamagnetic iron oxide nanoparticles/nanographene oxide (SPION/NGO) nanoparticles can be coated with copolymers PCL/chitosan to attain better colloidal stability in the biological environment. Nanoparticles were synthesized and characterized for their size, surface charge, X-ray patterns, polymer content, and in vitro heat-triggered release. In vitro cytotoxic effects of nanoparticles on CT-26 cells were assessed with an MTT assay and real-time polymerase chain reaction. In vivo tumor growth inhibition was evaluated on an allograft mouse model of CT-26 cells. Tumor-bearing mice were injected with 5-Fu-loaded nanoparticles intravenously, and then, the targeted delivery was amplified using a magnetic field and finally exposed to an alternating magnetic field (AMF) (40 A/m, 13.56 MHz), during which the tumor site temperature increased to 43 °C. By using an infrared camera, we managed to heat the nanoparticles up to a constant temperature between 42.5 and 43.5 °C, with a tolerance ±0.03 °C. Finally, in vitro results showed that 5-Fu-loaded nanoparticles combined with AMF hyperthermia significantly reduced the plating efficiency of the cells (

Identifiers

PMID34395970
PMCPMC8358959

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.